Liver Transplantation and Hepatitis C
Open Access
- 26 July 2012
- journal article
- review article
- Published by Hindawi Limited in International Journal of Hepatology
- Vol. 2012, 1-22
- https://doi.org/10.1155/2012/686135
Abstract
Hepatitis-C-virus- (HCV-) related end-stage cirrhosis is the primary indication for liver transplantation in many countries. Unfortunately, however, HCV is not eliminated by transplantation and graft reinfection is universal, resulting in fibrosis, cirrhosis, and finally graft decompensation. The use of poor quality organs, particularly from older donors, has a highly negative impact on the severity of recurrence and patient/graft survival. Although immunosuppressive regimens have a considerable impact on the outcome, the optimal regimen after liver transplantation for HCV-infected patients remains unclear. Disease progression monitoring with protocol biopsy and new noninvasive methods is essential for predicting patient/graft outcome and starting antiviral treatment with the appropriate timing. Antiviral treatment with pegylated interferon and ribavirin is currently considered the most promising regimen with a sustained viral response rate of around 30% to 35%, although the survival benefit of this regimen remains to be investigated. Living-donor liver transplantation is now widely accepted as an established treatment for HCV cirrhosis and the results are equivalent to those of deceased donor liver transplantation.Keywords
This publication has 177 references indexed in Scilit:
- Recipient-Donor race mismatch for African American liver transplant patients with chronic hepatitis CLiver Transplantation, 2011
- Liver Transplantation Trends in the HIV PopulationDigestive Diseases and Sciences, 2011
- Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than menJournal of Hepatology, 2011
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infectionJournal of Hepatology, 2010
- The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis CLiver Transplantation, 2009
- Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinomaJournal of Hepatology, 2007
- Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantationLiver Transplantation, 2006
- Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C-Infected Patients Undergoing Liver TransplantationAmerican Journal of Transplantation, 2005
- Donor age influences 10-year liver graft histology independently of hepatitis C virus infectionJournal of Hepatology, 2004
- Immunoprophylaxis with basiliximab, a chimeric anti[ndash ]interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipientsLiver Transplantation, 2002